ISTB | USTB | ISTB / USTB | |
Gain YTD | 5.196 | 4.784 | 109% |
Net Assets | 4.48B | 1.56B | 288% |
Total Expense Ratio | 0.06 | 0.35 | 17% |
Turnover | 39.00 | 60.00 | 65% |
Yield | 4.01 | 4.68 | 86% |
Fund Existence | 13 years | 8 years | - |
ISTB | USTB | |
---|---|---|
RSI ODDS (%) | 1 day ago4% | 1 day ago2% |
Stochastic ODDS (%) | 1 day ago16% | 1 day ago4% |
Momentum ODDS (%) | 1 day ago26% | N/A |
MACD ODDS (%) | 1 day ago18% | 1 day ago24% |
TrendWeek ODDS (%) | 1 day ago27% | 1 day ago22% |
TrendMonth ODDS (%) | 1 day ago30% | 1 day ago24% |
Advances ODDS (%) | 3 days ago25% | 3 days ago22% |
Declines ODDS (%) | 17 days ago24% | 29 days ago10% |
BollingerBands ODDS (%) | 1 day ago15% | N/A |
Aroon ODDS (%) | 1 day ago25% | 1 day ago25% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
GSLLX | 24.10 | N/A | N/A |
Goldman Sachs Enhanced U.S. Equity Inv | |||
MSAQX | 24.68 | N/A | N/A |
Morgan Stanley Inst Asia Opp I | |||
JACBX | 19.82 | N/A | N/A |
JHancock Mid Cap Growth I | |||
JFNAX | 67.19 | -0.01 | -0.01% |
Janus Henderson Global Life Sciences A | |||
RWEBX | 66.24 | -0.05 | -0.08% |
American Funds Washington Mutual R2E |
A.I.dvisor tells us that ISTB and SM have been poorly correlated (+3% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ISTB and SM's prices will move in lockstep.
Ticker / NAME | Correlation To ISTB | 1D Price Change % | ||
---|---|---|---|---|
ISTB | 100% | -0.08% | ||
SM - ISTB | 3% Poorly correlated | +0.07% | ||
PTEN - ISTB | 2% Poorly correlated | -2.49% |